PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 4/30
Copy link
Facebook
Email
Notes
More

Market Analysis and Trades for 4/30

PharmD_KS's avatar
PharmD_KS
Apr 30, 2025
∙ Paid
19

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 4/30
Copy link
Facebook
Email
Notes
More
2
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so there is no reason to subscribe to both.

The weekly post and video for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. Link to Market Analysis for The Week Ahead

SPY 0.00%↑

Bulls have continued to do everything they need to do to continue this uptrend. The overnight session got a bit volatile late in the Euro session but was stuffed at the major 5520-5525 weekly level which was a long setup for today:

The plan offered numerous setups on both sides of the tape including overnight and during the cash session, but it was the hold of 20-25 and reclaim of 5540 that set the tone for the day. Inventory continues to be stretched a bit long, and we are starting to see intraday liquidation breaks here and there. As long as these liquidation breaks aren’t met with follow on selling that finds traction below a prior day low, bulls can be fine. I remain quite cautious on rips, and patient on dips here. Tomorrow (and really the rest of the week) brings an enormous amount of data in the morning along with a ton of earnings so things can change quickly. As of now we have seen bulls continue to aggressively buy dips, and sellers (outside of Monday morning) have been content to sit passive at the highs without (yet) initiating lower.

Paid Content Below or in the Discord

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More